Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundThe acute myocardial infarction (AMI) is a prevalent and severe cardiovascular disease, characterized by its sudden onset, high mortality rate, and unfavorable prognosis.

Myocardial Infarction 52

Myocardial Infarction Diabetes Heart Failure Laboratory 52

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. Methods Data from the 2020 California State Inpatient Database was used retrospectively. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

European Journal of Heart Failure

FEBRUARY 16, 2025

ADHF-CS, acutely decompensated heart failure-related cardiogenic shock; AMI-CS, acute myocardial infarction-related cardiogenic shock; CI, confidence interval; HR, hazard ratio; MAP, mean arterial pressure; OPP, organ perfusion pressure; SOFA, Sequential Organ Failure Assessment. The primary outcome was in-hospital all-cause mortality.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Myocardial Infarction Heart Failure 40

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

Public Health 52

Public Health Myocardial Infarction STEMI Coronary Artery Disease 52

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Stroke 76

European Journal of Heart Failure

DECEMBER 13, 2023

Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Hospital 40

Heart BMJ

JANUARY 29, 2024

Objectives To ascertain whether invasive assessment of coronary physiology soon after recanalisation of the culprit artery by primary percutaneous coronary intervention is associated with the development of microvascular obstruction by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction Physiology STEMI 40

Coronary Artery Disease Journal

JUNE 10, 2024

Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. Methods The National Inpatient Sample database (2009–2020) was used to study trends in admissions and outcomes of post-STEMI VSR over time. and 10 ± 1.2%

Myocardial Infarction 40

Myocardial Infarction STEMI Outcomes Inpatient 40

Circulation

NOVEMBER 11, 2024

Despite this, little is known regarding the outcomes of 30-day re-admissions following Acute Myocardial Infarction (AMI) in the context of group 2 PH.Hypothesis:Group 2 PH is associated with a higher likelihood of 30-day readmissions in patients presenting with AMI.Goal:To assess the relationship between group 2 PH and adverse hospitalization outcomes (..)

Myocardial Infarction 40

Myocardial Infarction Hospital Hypertension Pulmonary 40

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundAcute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is associated with significant morbidity and mortality. A total of 406 patients were enrolled at 80 sites between 2016 and 2020. Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Blood Pressure Cardiac Arrest 40

Journal of Cardiothoracic Surgery

APRIL 7, 2024

Pulmonary embolism is the most common cardiovascular disease after myocardial infarction and stroke. Konstantinides (Eur Heart J 41(4):543–603, 2020) Current guidelines categorize patients with PE as being at.

Embolism 52

Embolism Pulmonary Myocardial Infarction Cardiovascular Disease 52

Coronary Artery Disease Journal

MAY 29, 2024

Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional risk factors such as serum iron levels. μmol/L) and a control group (Fe ≥7.8 μmol/L). μmol/L).

Myocardial Infarction 40

Myocardial Infarction Hospital STEMI Risk Factors 40

The American Journal of Cardiology

DECEMBER 17, 2023

Publication date: Available online 16 December 2023 Source: The American Journal of Cardiology Author(s): Karthik Gonuguntla, Yasar Sattar, Kinza Iqbal, Aakanksha Sharma, Ritu Yadav, Anas Alharbi, Muchi Ditah Chobufo, Minahil Naeem, Ayesha Shaik, Sudarshan Balla

Myocardial Infarction 40

Myocardial Infarction 40

Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. reduction in admissions in 2020. reduction in admissions in 2020. In 2020, 3.0% vs. 10.7%; P < 0.001). compared to 10.7%

COVID-19 52

COVID-19 STEMI Inpatient Hospital 52

Journal of the American Heart Association

DECEMBER 14, 2024

This study aimed to assess whether statin use could lead to better outcomes among individuals with AF.Methods and ResultsWe enrolled 397 787 patients with AF from January 1, 2012 to December 31, 2020.

Atrial Fibrillation 75

Atrial Fibrillation Myocardial Infarction Hemorrhage Heart Failure 75

DAIC

DECEMBER 14, 2023

The NCSI participating hospitals agreed to treat patients who presented with acute myocardial infarction and cardiogenic shock using a standard protocol, which involved rapid initiation of mechanical circulatory support (MCS) with an Impella 2.5 Patients were enrolled between July 2016 and December 2020.

Cardiogenic Shock 105

Cardiogenic Shock Heart attacks Heart Attack Myocardial Infarction 105

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Open Heart

SEPTEMBER 23, 2022

Methods We used the University of Ottawa Heart Institute Revascularisation Registry to identify patients who underwent revascularisation between August 2015 and March 2020, who were prospectively followed for an average of one year. We conducted a retrospective cohort study analysing the association between AF and clinical outcomes.

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Risk Factors Outcomes 52

Open Heart

JUNE 5, 2024

Results From 1 January 2005 to 31 December 2020, 2727/18 988 (14.4%) patients were SMuRF less, with the proportion increasing over time. vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1% Secondary outcomes included in-hospital and 30-day events. vs 25.4%, p<0.001). vs 3.6%, p=0.019) and arrhythmia (11.2%

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

DAIC

JULY 18, 2024

Cardiovascular disease is the most common cause of death and disability globally, largely driven by myocardial infarction and ischemic stroke caused by atherosclerosis (plaque build-up in the arteries). 2017 23, April 2020; Available from: [link]. Cardiovasc. 6 (3) (2019).

Plaque 105

Plaque Heart attacks Heart Attack Cardiovascular Disease 105

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Patients and methods From December 2009 to June 2020, 388 elective patients were included in our retrospective study. IPTW-adjusted Kaplan–Meier estimates by study group were calculated for all-cause mortality, stroke, the risk of repeat revascularization and myocardial infarction up to a maximum follow-up of 10 years.

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Myocardial Infarction Outcomes Stroke 64

Stroke Journal

DECEMBER 5, 2024

Similarly, for MI survivors and healthy adults, we used the 2011 guidelines for secondary prevention of coronary vascular diseases and the 2020 World Health Organization physical activity guidelines, respectively. This study aims to determine the adherence to physical activity recommendations among stroke survivors in the United States.

Stroke 75

Stroke Strokes Myocardial Infarction Education 75

DAIC

MARCH 28, 2024

Primary adverse events were defined as myocardial infarction, thromboembolism, transient ischemic attack, diaphragmatic paralysis, pneumothorax, heart block, pulmonary edema, vagal nerve injury, pericarditis, major vascular access complication or bleeding, death, stroke, or any other cerebrovascular accident. Epub 2020 Jan 19.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

Open Heart

NOVEMBER 20, 2023

Data were fitted to segmented regression models with March 2020 as the breakpoint. Data on 21 001 patients were included (7057 ST-elevation myocardial infarction (STEMI), 7649 non-ST elevation myocardial infarction (NSTEMI) and 6295 unstable angina).

COVID-19 52

COVID-19 Hospital Angina Myocardial Infarction 52

Dr. Smith's ECG Blog

APRIL 22, 2024

EKG from triage: Here is his previous ECG: Normal ST Elevation Resident's interpretation: Reperfusion pattern/Wellens' with biphasic T waves in V2 and V3, and in comparison to an EKG in 2020 this is new. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am Heart J.

Chest Pain 117

Chest Pain Myocardial Infarction Anatomy Angina 117

Open Heart

JANUARY 27, 2023

Background ST elevation myocardial infarction (STEMI) represents a cardiac emergency. Methods We performed a single-centre retrospective cohort analysis of all patients admitted to our hospital from 2008 to 2020 with a diagnosis of inferior STEMI. Inferior STEMI represents a dilemma for cardiologists.

STEMI 52

STEMI Myocardial Infarction Hospital 52

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Frontiers in Cardiovascular Medicine

APRIL 17, 2024

ObjectiveCardiac regenerative medicine has gained significant attention in recent years, and integrins are known to play a critical role in mediating cardiac development and repair, especially after an injury from the myocardial infarction (MI).

Research 52

Research Myocardial Infarction Circulation 52

Dr. Smith's ECG Blog

MAY 30, 2023

Literature cited In inferior myocardial infarction, neither ST elevation in lead V1 nor ST depression in lead I are reliable findings for the diagnosis of right ventricular infarction Johanna E. The February 11, 2020 post ( LA-RA reversal ). The March 18, 2020 post ( LA-RA reversal ). Bischof , Christine I.

Chest Pain 97

Chest Pain Myocardial Infarction STEMI Cardiogenic Shock 97

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 8, 2024

However, data on whether a high-sensitivity HEART Pathway (hs-HP) are safe and effective is lacking.METHODS:An interrupted time series study was conducted at 5 North Carolina sites in 26 126 adult emergency department patients being investigated for possible acute coronary syndrome and without ST-segment–elevation myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction Chest Pain Electrocardiogram Risk Factors 40

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Methods We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 during the execution of this review. The models were mainly constructed using data from individuals diagnosed with ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 59

Myocardial Infarction STEMI Article Diabetes 59

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Methods All consecutive patients from the France PCI registry treated by PCI and discharged with OAC between 2014 and 2020 were included and followed one-year. A propensity-score analysis was used.

Myocardial Infarction 49

Myocardial Infarction Academic Research Stroke 49

Circulation

NOVEMBER 11, 2024

The secondary outcomes comprise the odds of adverse events, including myocardial infarction, ischemic stroke, transient ischemic attack (TIA), occlusive atherosclerotic disease, percutaneous coronary intervention, and coronary artery bypass graft (CABG)., The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Open Heart

NOVEMBER 14, 2023

Methods We used the Swedish Registry of Cardiopulmonary Resuscitation, merged with the Inpatient Registry and Outpatient Registry to identify patients with OHCA from 2010 to 2020 and to collect all their comorbidities as well as discharge diagnoses (among those admitted to hospital).

Cardiac Arrest 52

Cardiac Arrest Coronary Artery Disease Hospital Heart Failure 52

Heart BMJ

NOVEMBER 27, 2023

Two 28-day to 1-year postdischarge multivariable risk prediction scores were developed: (1) cardiovascular mortality/rehospitalisation with myocardial infarction or ischaemic stroke (ischaemic score) and (2) bleeding mortality/rehospitalisation with bleeding (bleeding score). to 0.77) and 0.69 (95% CI, 0.67 to 0.71), respectively).

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Stroke Strokes 52

Dr. Smith's ECG Blog

DECEMBER 27, 2023

Comparative early and late outcomes after primary percutaneous coronary intervention in st-segment elevation and Non–St-segment elevation acute myocardial infarction (from the Cadillac trial). Immediate and early percutaneous coronary intervention in very high‐risk and high‐risk non‐st segment elevation myocardial infarction patients.

Chest Pain 130

Chest Pain Myocardial Infarction Blog Stent 130

Journal of the American Heart Association

FEBRUARY 8, 2025

Hazard ratios (HRs) for the primary end point (allcause mortality, stroke, or myocardial infarction) and secondary end point (including major bleeding) were 3.09 (95% CI, 2.733.21) and 2.96 (95% CI, 2.733.21) for patients 80 years, compared with younger patients. of AF cases.

Atrial Fibrillation 45

Atrial Fibrillation Outcomes Myocardial Infarction Risk Factors 45